OBJECTIVE: The pattern of @entity1486 (PSA) testing in clinical practice is largely unknown; it may be used either in asymptomatic @entity1 or in the work-up of @entity1 with urinary or other symptoms. The aim of this study was to investigate the pattern of PSA testing in clinical practice for @entity1 diagnosed with stage @entity263 in a region with no formal screening programme. MATERIAL AND METHODS: Using the Primary @entity263 Register for Northern Sweden, all cases of stage @entity263 diagnosed between 1992 and 1999 in the city of Ume   were identified. The cause of PSA testing was assessed by examining the medical records. @entity1 were categorized as asymptomatic, having lower urinary tract symptoms (LUTS) or having symptoms other than LUTS. Prospective registration of the cause of PSA testing in the entire region of Northern Sweden started in 2000. RESULTS: We found that in Ume   only 32/213 (15%) cases diagnosed with @entity263 were asymptomatic at the time of PSA testing, 55% of @entity1 had a PSA test as part of a work-up for LUTS and 30% had other symptoms. In 2000, 126 cases of stage @entity263 were diagnosed in the entire region and 20/126 (16%) of these @entity1 were asymptomatic. CONCLUSIONS: PSA testing was mostly used as a tool in the work-up of symptomatic @entity1 in Ume   and also in the region of Northern Sweden. Further studies in other populations are needed.

Population-based study of @entity1486 testing and XXXX detection in clinical practice in northern Sweden.

@entity1 :: ('9606', 'Species') :: ['patients', 'Men', 'men'] @entity263 :: ('MESH:D011471', 'Disease') :: ['T1c prostate cancer', 'Prostate Cancer'] @entity1486 :: ('354', 'Gene') :: ['prostate-specific antigen']
@entity263 :: (MESH:D011471,Disease) :: ['prostate cancer']
